Description

Triflusal is a synthetic salicylate derivative with potent antiplatelet and anti-inflammatory properties. This active pharmaceutical ingredient (API) is valued for its specific mechanism of action, which differs from other common platelet aggregation inhibitors, offering a distinct therapeutic profile. It is primarily required by pharmaceutical manufacturers and research institutions for the development and production of cardiovascular and cerebrovascular medications, as well as for advanced pharmacological studies.

Application

• Pharmaceutical API: Core active ingredient in the formulation of antiplatelet drugs for the prevention of thromboembolic events, such as stroke and myocardial infarction.
• Cardiovascular Research: A key compound in preclinical and clinical research investigating novel pathways for platelet inhibition and vascular protection.
• Neuroprotective Agent Development: Used in studies targeting ischemic stroke and other conditions where reducing platelet aggregation and inflammation is crucial.
• Comparative Pharmacological Studies: Serves as a reference standard in research comparing the efficacy and safety profiles of different antiplatelet therapies.
• Analytical Reference Standard: High-purity grade used for quality control testing, method development, and calibration in analytical laboratories.
• Formulation Development: Employed in the development of various dosage forms, including tablets and capsules, ensuring stability and bioavailability.

Basic Information

Item	Detail
Product Name	Triflusal
CAS No.	322-79-2
Molecular Formula	C10H7F3O4
Molecular Weight	248.16 g/mol
Synonyms	2-Acetoxy-4-(trifluoromethyl)benzoic Acid; 4-Trifluoromethylaspirin; Disgren; Triflux; UR-1501; 2-(Acetyloxy)-4-(trifluoromethyl)benzoic Acid
EINECS	206-294-3

Quality Control

Our Triflusal is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including identification, purity assay, and impurity profiling via techniques such as HPLC, IR spectroscopy, and residual solvent analysis. We provide full traceability and Certificates of Analysis (COA) are supplied with every shipment, ensuring compliance with current Good Manufacturing Practice (cGMP) principles and relevant pharmacopeial standards for active pharmaceutical ingredients.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Related Substances (HPLC)	Individual impurity: ≤ 0.5% Total impurities: ≤ 1.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.